Loading…
Back To Schedule
Tuesday, March 14 • 4:45pm - 5:45pm
Panel: The VC Perspective: Deal Drivers, Financing Options and Trends for 2023

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
  • Understanding the different approaches taken by VCs for their financing models
  • Looking at the biggest opportunities for growth
  • What metrics and criteria are VCs looking at during their diligence process and what drives their decision making especially in the current economic climate?
  • Vetting your VCs: Factors to take into consideration when deciding what route to take
Moderators
avatar for Laura Berner

Laura Berner

Chief Operating Officer, TRexBio
Laura Berner brings extensive experience in corporate development, corporate and strategic transactions, investor relations, strategy and operations to her role as Chief Operating Officer of TRexBio. Most recently, she was VP, Head of Business Development & Investor Relations at Myovant... Read More →

Speakers
avatar for Seth Lieblich

Seth Lieblich

Principal, 8VC
Seth joined 8VC from Amgen’s Business Development technology group, where he was responsible for search & evaluation and transactions for platform technologies across a number of therapeutic and functional areas. Seth was also responsible for strategic academic partnerships across... Read More →
avatar for Mariana Mihalusova, PhD, MBA

Mariana Mihalusova, PhD, MBA

Vice President, Venrock
Mariana Mihalusova focuses on biotech and pharmaceutical investments, and is currently a Board Observer at Mythic Therapeutics and Ocelot Bio. Mariana brings to Venrock deep experience spanning the entire spectrum of drug development – from preclinical, to marketing approval, to... Read More →
avatar for Christopher Mauney

Christopher Mauney

Senior Associate, NovaQuest Capital Management
Chris Mauney, Senior Associate at NovaQuest Capital Management, has experience advancing a range of drug development and regulatory programs across diverse indications and therapeutic modalities. He is responsible for due diligence, structuring of investment opportunities, and post-close... Read More →

Tuesday March 14, 2023 4:45pm - 5:45pm PDT
Hyatt Centric Fisherman's Wharf San Francisco

Attendees (16)